Pharmacology

A New Class of Malaria Drug Candidates

...

Blog Post - Scott Beers - Sep 30 2019 - 7:50am

Prebiotics Do More Harm Than Good

Though prebiotics are a fad outside the chemotherapy sector, there is little evidence they do anything positive or negative in humans. Except in horses, where they seem to do something negative. Before they can reach the intestines, commercially available ...

Article - News Staff - Oct 2 2019 - 6:53pm

Reyvow (Lasmiditan) For Migraine Headaches Gets FDA Approval

The U.S. Food and Drug Administration has approved Eli Lilly and Company's Reyvow (lasmiditan) tablets for acute treatment of migraine headaches in adults. Though used colloquially by everyone who feels like their headache is bad, a clinical migraine ...

Article - News Staff - Oct 11 2019 - 2:34pm

The Alternative To Opioids May Come From Tasmanian Waters

There is a war on opioids and legitimate pain patients have been caught in the stigma of recreational abuse. High-profile class action lawsuits against drug manufacturers are going to create an "icy chill" for pain medication just as they ran ant ...

Article - News Staff - Oct 15 2019 - 11:44am

FDA Blasts Chiropractor Cade Copeland Of Rooted Apothecary For Claiming His CBD Helps Autism, ADHD, Parkinson’s, Alzheimer’s

Fresh off poisoning thousands by introducing tainted, illegal additives into vaping devices (including dangerous synthetic marijuana, which just resulted in a conviction), the marijuana supplement industry (cannabidiol, CBD) is under scrutiny again. This t ...

Article - News Staff - Oct 22 2019 - 10:03am

Marijuana As Magic: CBD Search Increases Are Making The Rest Of The Supplement Industry Nervous

Though a CBD supplement huckster was just convicted for selling synthetic marijuana and CBD oil is the culprit behind untold numbers of vaping illnesses and deaths, and a chiropractor was just lambasted by FDA for claiming his CBD supplement can fix everyt ...

Article - Hank Campbell - Oct 23 2019 - 12:55pm

Marijuana Cannabinoids Don't Help With Depression, Anxiety, ADHS, Tourettes, Psychosis, Or PTSD

Though cannabinoids in marijuana are touted by salespeople and supplement marketing as therapies for almost anything, anecdotes are not evidence, and the evidence from a meta-analysis of 83 studies (3,000 people) for six mental health conditions shows cann ...

Article - News Staff - Oct 28 2019 - 5:30pm

Shire Announces Launch Of FOSRENOL(R) In Japan

Shire plc today announces the Japanese launch of FOSRENOL(R) (lanthanum carbonate), which is now available to prescribers and patients in Japan through Shire's strategic alliance partner Bayer Yakuhin Ltd. FOSRENOL is the first commercially available ...

Article - Anna Ohlden - Nov 4 2019 - 11:21am

Pushing Back The Frontiers Of Malaria One African Collaboration At A Time

More than 200 million people around the world suffered from malaria in 2017. Over 400,000 died. The vast majority – around 90% – were in Africa, where many are all too familiar with the devastating impact of the disease. Young children and pregnant women ...

Article - The Conversation - Nov 19 2019 - 5:01am

Coartem, The First Dispersible ACT For Children, Launched This Week In Africa By Novartis And Medicines For Malaria Venture

Novartis and Medicines for Malaria Venture (MMV) announced today the African launch of Coartem(R) Dispersible. Coartem(R) Dispersible is the result of a unique public-private collaboration between Novartis and the nonprofit Medicines for Malaria Venture ( ...

Article - Anna Ohlden - Nov 19 2019 - 11:42am